External Quality Assessment for the Detection of Chlamydia trachomatis in Urine Using Molecular Techniques in Belgium

Table 3

Method used per year and per participant.

Methods	2008a	2008b	2009	2010	2011a	2011b	2012
Real time PCR
Abbott real time CT^1	1	2	2	2	2	2	2
Abbott real time CT/NG^1		1	2	8	10	13	15
Nanogen Chlamydia tr. Q-PCR Alert kit^2		1	1	1	1	1	1
Shangai bio-tech IMtec CT real time PCR kit^3		1
Roche Cobas TaqMan CT^4	4	4	9
Roche Cobas TaqMan CT v2.0 Roche^4				14	14	12	12
Roche Cobas TaqMan CT/NG^4			1			3	7
Qiagen artus C. trachomatis PCR kit^5	5	5	7	5	5	5	4
Diagenode DIA-CT-050^6				1	1	2	1
Real time in house	1	3		5	3	4	4
Gen-Probe Aptima combo 2 Assay^7		1
Gen-Probe PACE CT^7		1
Gen-Probe PACE 2 CT^7
SDA
Becton Dickinson ProbeTec ET^8	11	10	9	7	6	6	5
PCR-ELISA
Roche Amplicor CT^4	1
Roche Amplicor CT/NG^4	12	11		8	4	2	3
Roche Cobas Amplicor CT/NG^4	10	10	17	3	4	1	1
Other
Nasba in house	2
Hain Lifescience Genoquick CT^9			1
Total of the participants	47	50	48	54	50	51	55

Abbott laboratories, Abbott Park, IL, USA.
²Nanogen Advanced Diagnostics, Trezzano sul Naviglio, Italy.
³IMTEC, Berlin, Germany.
⁴Roche Molecular diagnostics, Pleasanton, USA.
⁵Qiagen, Venlo, Netherlands.
⁶Diagenode, Liège, Belgium.
⁷Gen-Probe Incorporated, San Diego, USA.
⁸Becton Dickinson and Co, Sparks, USA.
⁹Hain Lifesceince GmBH, Nehren, Germany.